Oruka Therapeutics (ORKA) EV/FCF: History & Chart

Oruka Therapeutics, Inc.(ORKA)

Biotechnology · Menlo Park, CA

$79.81-4.57 (-5.42%)

Delayed quote: Oct 6, 2026, 2:20 PM EDT

About Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Menlo Park, CA

68 employees

www.orukatx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Lawrence Otto Klein

View full financials

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Oruka Therapeutics, Inc. (ORKA)	$4.81B	N/A	N/A	N/A	N/A
Mirum Pharmaceuticals, Inc. (MIRM)vs ›	$4.80B	N/A	99.69x	99.69x	99.69x
Dianthus Therapeutics, Inc. (DNTH)vs ›	$4.71B	N/A	N/A	N/A	N/A
BillionToOne, Inc. (BLLN)vs ›	$4.71B	129.84x	178.16x	178.16x	178.16x
LifeStance Health Group, Inc. (LFST)vs ›	$4.68B	26.77x	24.76x	35.67x	35.67x
Definium Therapeutics, Inc. (DFTX)vs ›	$4.68B	N/A	N/A	N/A	N/A
Option Care Health, Inc. (OPCH)vs ›	$4.65B	N/A	20.21x	23.58x	29.57x
Erasca, Inc. (ERAS)vs ›	$4.98B	N/A	N/A	N/A	N/A
Waystar Holding Corp. (WAY)vs ›	$5.04B	26.42x	22.66x	283.41x	283.41x
Merit Medical Systems, Inc. (MMSI)vs ›	$5.06B	26.69x	27.85x	42.08x	46.24x

NAME

MARKET CAP

EV/FCF RATIO

TTM

Oruka Therapeutics, Inc. (ORKA)

$4.81B

N/A

Mirum Pharmaceuticals, Inc. (MIRM)vs ›

$4.80B

N/A

99.69x

Dianthus Therapeutics, Inc. (DNTH)vs ›